IMEDEX Biomatériaux (IMEDEX) develops proprietary collagen biomaterials to heal external or internal wounds. IMEDEX's two lead development-stage products are designed to seal and to protect surgical wounds, stop bleedings, prevent blood, fluid and air leaks in a wide variety of tissues, attach prostheses, form anti-adhesion barriers and deliver therapeutics. In so doing, these products have the potential to significantly improve clinical outcomes and address large markets that are underserved by current commercial products.
Activity:
- Manufacturing
Product / Technology type(s) covered:
- Bio
- Drug delivery
- Pharmaceuticals / Therapeutics
Therapeutic targets:
- Dermatology
- Surgery
|
|